New Study Examines Injured Workers' Opioid Use By States

Comparing opioid use for workers injured in 2010 and 2013 over an average two-year period following the injury, the study found reductions in the average amount of opioids dispensed to injured workers in several states, with larger reductions seen in Kentucky, Maryland, Michigan, and New York.

A study released this week by the Workers Compensation Research Institute found decreases in the frequency and amount of opioids dispensed to injured workers in most of the study states, although higher use of opioids and other high-risk utilization patterns were seen in some states in the most recent study period. The study data are from October 2009 through March 2015.

"This report serves as a tool to monitor ongoing policy changes on opioid utilization in 26 state workers' compensation systems. By comparing variations in the use of opioids across the states, this study can help policymakers and stakeholders be better informed about the level of opioid use in their states and better target future efforts to address issues related to prescription opioids in their states," said Ramona Tanabe, WCRI's executive vice president and in-house counsel.

The study, "Interstate Variations in Use of Opioids, 4th Edition," examines interstate variations and trends in the use of opioids and prescribing patterns of pain medications across 26 state comp systems. It found:

  • Comparing opioid use for workers injured in 2010 and 2013 over an average two-year period following the injury, the study found reductions in the average amount of opioids dispensed to injured workers in several states, with larger reductions seen in Kentucky, Maryland, Michigan, and New York.
  • Despite the reductions, however, opioid use was prevalent among nonsurgical claims with more than seven days of lost time. In 2013/2015, about 65 to 75 percent of these injured workers with pain medications received at least one opioid prescription in most of the study states. The proportion was higher in Arkansas (85 percent), Louisiana (80 percent), and South Carolina (80 percent).
  • The average amounts of opioids received in Louisiana, New York, and Pennsylvania continued to be the highest among the 26 study states for claims with opioids. "Although New York is among the states with a higher-than-typical amount, it is important to note the substantial decrease in both the frequency and amount of opioids in New York over the study period," WCRI noted.
  • The study noted a sizable percentage of claims with opioids that were receiving chronic opioids (at least 60 days of opioids supply over any 90-day period) and at higher doses (average daily dose of opioids exceeding 50 and 90 morphine equivalent milligrams).
  • Among claims with opioids, simultaneous use of opioids with at least one other sedating drug was seen in one-third to half of injured workers across the 26 states. Muscle relaxants and opioids were dispensed together in 28-48 percent of claims with opioids,while use of both opioids and benzodiazepines at the same time was seen in 0-9 percent of claims.

The study used data comprising more than 430,000 nonsurgical workers' compensation claims and nearly 2.3 million prescriptions associated with those claims from 26 states; data included in this study represented 36-69 percent of workers' compensation claims in each state; the 26 states included in this study were Arkansas, California, Connecticut, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nevada, New Jersey, New York, North Carolina, Pennsylvania, South Carolina, Tennessee, Texas, Virginia, and Wisconsin, which combined represent more than two-thirds of the workers' compensation benefits paid in the United States.

Product Showcase

  • Matrix's OmniPro Vision AI Collision Avoidance System

    OmniPro Vision AI is a state-of-the-art collision avoidance system that features NIOSH award-winning Visual Artificial Intelligence (AI) technology. This highly accurate, powerful system identifies and alerts on pedestrians, vehicles and specified objects, ensuring safer facilities, mining operations and industrial sites. With its web-based cloud application, OmniPro Vision AI also logs and analyzes a wide range of data related to zone breach notifications. Operating without needing personal wearable devices or tags, OmniPro has visual and audible zone breach alerts for both operators and pedestrians. Read More

  • Magid® D-ROC® GPD412 21G Ultra-Thin Polyurethane Palm Coated Work Gloves

    Magid’s 21G line is more than just a 21-gauge glove, it’s a revolutionary knitting technology paired with an advanced selection of innovative fibers to create the ultimate in lightweight cut protection. The latest offering in our 21G line provides ANSI A4 cut resistance with unparalleled dexterity and extreme comfort that no other 21-gauge glove on the market can offer! Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

Featured

Artificial Intelligence